RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Daqing Wu to Drug Screening Assays, Antitumor

Back to Details
This is a "connection" page, showing publications Daqing Wu has written about Drug Screening Assays, Antitumor.
Daqing Wu
Connection Strength
0.176
Drug Screening Assays, Antitumor
  1. Zhao R, Ma X, Bai L, Li X, Mamouni K, Yang Y, Liu H, Danaher A, Cook N, Kucuk O, Hodges RS, Gera L, Wu D. Overcoming prostate cancer drug resistance with a novel organosilicon small molecule. Neoplasia. 2021 12; 23(12):1261-1274.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support